Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of 16c/Sh.
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Total operating expenses: 29.1M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Total operating expenses: 29.1M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q3 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $3.46 million versus the consensus estimate of $3.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Pentair (PNR) Tops Q1 EPS by 4c, Misses on Revenue; Offers FY24 EPS Guidance
- Kiniksa Pharmaceuticals, Ltd. (KNSA) Misses Q1 EPS by 11c; raises guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
